Nanjing Hicin Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Nanjing Hicin Pharmaceutical has a total shareholder equity of CN¥1.0B and total debt of CN¥270.6M, which brings its debt-to-equity ratio to 27%. Its total assets and total liabilities are CN¥1.4B and CN¥411.0M respectively. Nanjing Hicin Pharmaceutical's EBIT is CN¥46.9M making its interest coverage ratio 6.1. It has cash and short-term investments of CN¥19.9M.
Key information
27.0%
Debt to equity ratio
CN¥270.55m
Debt
Interest coverage ratio | 6.1x |
Cash | CN¥19.87m |
Equity | CN¥1.00b |
Total liabilities | CN¥411.05m |
Total assets | CN¥1.41b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300584's short term assets (CN¥353.4M) do not cover its short term liabilities (CN¥389.6M).
Long Term Liabilities: 300584's short term assets (CN¥353.4M) exceed its long term liabilities (CN¥21.5M).
Debt to Equity History and Analysis
Debt Level: 300584's net debt to equity ratio (25%) is considered satisfactory.
Reducing Debt: 300584's debt to equity ratio has increased from 19.8% to 27% over the past 5 years.
Debt Coverage: 300584's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 300584's interest payments on its debt are well covered by EBIT (6.1x coverage).